Chemoinformaics analysis of Propyl 2-methylbutyrate
| Molecular Weight | 144.214 | nRot | 4 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 1 |
| Exact Molecular Weight | 144.115 | nRing | 0 |
| Solubility: LogS | -1.914 | nHRing | 0 |
| Solubility: LogP | 2.524 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.6327 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.444 |
| Synth | 2.37 |
| Natural Product Likeliness | 2.041 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.465 |
| HIA | 0.004 |
| CACO-2 | -4.119 |
| MDCK | 0.0000381 |
| BBB | 0.954 |
| PPB | 0.767012 |
| VDSS | 1.231 |
| FU | 0.323654 |
| CYP1A2-inh | 0.717 |
| CYP1A2-sub | 0.533 |
| CYP2c19-inh | 0.089 |
| CYP2c19-sub | 0.275 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.808 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.183 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.122 |
| CL | 9.926 |
| T12 | 0.798 |
| hERG | 0.023 |
| Ames | 0.022 |
| ROA | 0.028 |
| SkinSen | 0.931 |
| Carcinogencity | 0.208 |
| EI | 0.994 |
| Respiratory | 0.091 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.938148 |